Status:
UNKNOWN
3D vs 2D-laparoscopy for Rectocele and Rectal Prolapse Correction: a Prospective, Randomized, Single Center Study
Lead Sponsor:
Alexander Khitaryan
Conditions:
Rectocele; Female
Rectocele and Incomplete Uterine Prolapse
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The aim is to compare proximate and remote results of 3D and conventional 2D laparoscopic interventions in terms of efficacy and safety in treatment of symptomatic rectocele and rectal prolapse. This...
Eligibility Criteria
Inclusion
- stage 3 rectocele (3-4 POP-Q grade) and/or full-thickness rectal prolapse
- age 18-70 y.o.
Exclusion
- severe concomitants chronic diseases (American Society of Anesthesiologists class III - IV),
- ongoing oncological diseases,
- ongoing hematological diseases,
- ongoing inflammatory diseases of the colon and pelvic organs,
- pregnancy
Key Trial Info
Start Date :
March 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04817150
Start Date
March 10 2021
End Date
July 1 2022
Last Update
April 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Private Healthcare Institution Clinical Hospital "RGD-Medicine" Rostov-on-Don"
Rostov-on-Don, Russia, 344010